SLE patients’ CD4+ T cells have hypoacetylated histones [265,332], and treating lupus-prone mice with histone deacetylase inhibitors alleviated disease severity by downregulating proinflammatory cytokines [333]. This evidence concerns the gene CD4 and systemic lupus erythematosus.